New research suggests that a procedure now regarded as Plan B when patients have episodes of rapid heartbeat after a heart ...

From its cardiovascular divisions, Medtronic brought in $3.1 billion for an increase of 6.1%—driven in part by the launches ...

CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...

With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Analyst Travis Steed of Bank of America Securities reiterated a Buy rating on Medtronic (MDT – Research Report), retaining the price target of ...

Researchers from Tampere University, the University of Jyvaskyla, and the University of Vaasa developed a multi-agent LLM ...

ST. LOUIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally ...

Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...

Diabetes shines, cardiac ablation stumbles, and new products spark hope--Medtronic's Q2 FY25 shakes up expectations.

The high cost of advanced EP diagnostic catheters could hinder accessibility, particularly in cost-sensitive healthcare ...

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

There is no credible evidence supporting false claims that listening to soundwaves of a specific frequency can safely "kill ...